This research explores how immune-related cells and molecules, beneficial in wound healing, may become harmful in Parkinson’s disease. Using the fruit fly as a model organism, the study investigates which inflammatory processes contribute to brain damage. Early results suggest that excessive activation worsens degeneration, offering potential targets for future therapies.

This research investigates how melanoma switches between two gene states—one fast-growing and treatable, the other slow but highly invasive and responsible for brain metastases. By identifying genes that control this transition, the study aims to force melanoma into a more treatable form, improving therapeutic options and patient outcomes.

Liver cancer alters how cells use sugar long before tumors are visible. This research makes sugar detectable by MRI, allowing real-time imaging of cancer metabolism inside the liver. By revealing how tumors process energy differently from healthy tissue, the technique could enable earlier diagnosis, monitor treatment response, and improve patient survival.

Genetic cardiomyopathies arise from DNA errors that disrupt vital heart proteins and can be fatal in childhood. This research improves heart-targeted gene therapy by guiding treatments through the bloodstream using chemokine “traffic signals” and avoiding immune interference, enabling therapies to reach the heart more efficiently and potentially cure inherited heart disease.

A researcher explains how anatomical differences in the vagus nerve drive inconsistent outcomes in epilepsy treatment. By dissecting and 3D-mapping human vagus nerves, the team reveals major left–right differences, enabling more precise electrode placement. This work promises safer, more effective nerve stimulation therapies for epilepsy and other diseases.